Protagonist to Present Preclinical Findings on PTG-200 for Crohn’s Disease at Conference
News
Protagonist Therapeutics will present preclinical research data on its investigational drug PTG-200 as a potential treatment for Crohn’s disease. The findings will be presented May 6 at the Digestive Disease Week conference ... Read more